Miller DD - Search Results

1

Interaction of permanently charged metoclopramide analogs with D-2 dopamine receptors.

Farooqui T, Brooks K, Harrold MW, Miller DD, Wallace LJ, Uretsky NJ. Farooqui T, et al. Among authors: miller dd. Gen Pharmacol. 1994 Dec;25(8):1577-84. doi: 10.1016/0306-3623(94)90357-3. Gen Pharmacol. 1994. PMID: 7721031

2

Interaction of permanently charged chlorpromazine and dopamine analogs with the striatal D-1 dopaminergic receptor.

Wallace RA, Wallace L, Harrold M, Miller D, Uretsky NJ. Wallace RA, et al. Biochem Pharmacol. 1989 Jun 15;38(12):2019-25. doi: 10.1016/0006-2952(89)90502-9. Biochem Pharmacol. 1989. PMID: 2525907

3

Interaction of permanently charged analogs of dopamine with the D-2 dopaminergic receptor.

Wallace RA, Farooqui T, Wallace L, Ares J, Chang YA, Miller D, Uretsky N. Wallace RA, et al. Biochem Pharmacol. 1987 Nov 15;36(22):3903-10. doi: 10.1016/0006-2952(87)90456-4. Biochem Pharmacol. 1987. PMID: 2961340

4

Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor.

Wallace RA, Farooqui T, Wallace L, Ares J, Chang YA, Miller D, Uretsky N. Wallace RA, et al. Biochem Pharmacol. 1988 May 15;37(10):2077-84. doi: 10.1016/0006-2952(88)90559-x. Biochem Pharmacol. 1988. PMID: 2967702

5

Interaction of AZA analogs of chlorpromazine with the dopamine D2 receptor.

Farooqui T, Markovich K, Wallace L, Miller D, Uretsky N. Farooqui T, et al. Gen Pharmacol. 1993 Jan;24(1):147-51. doi: 10.1016/0306-3623(93)90026-t. Gen Pharmacol. 1993. PMID: 8482489

6

Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride.

Harrold MW, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD. Harrold MW, et al. Among authors: miller dd. J Med Chem. 1989 Apr;32(4):874-80. doi: 10.1021/jm00124a024. J Med Chem. 1989. PMID: 2522993

7

Effect of the inhibition of dopamine uptake on the dopamine- and dimethyldopamine-induced-inhibition of the potassium-evoked release of [3H]acetylcholine from striatal slices.

Farooqui T, Wallace RA, Miller DD, Uretsky NJ. Farooqui T, et al. Among authors: miller dd. Gen Pharmacol. 1989;20(6):731-6. doi: 10.1016/0306-3623(89)90320-0. Gen Pharmacol. 1989. PMID: 2591702

8

Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.

Sabol B, Boldry R, Farooqui T, Chang YA, Miller D, Uretsky N. Sabol B, et al. Biochem Pharmacol. 1987 May 15;36(10):1679-85. doi: 10.1016/0006-2952(87)90054-2. Biochem Pharmacol. 1987. PMID: 3109428

9

Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.

Shin Y, Romstedt KJ, Doyle K, Harrold MW, Gerhardt MA, Miller DD, Patil PN, Feller DR. Shin Y, et al. Among authors: miller dd. Chirality. 1991;3(2):112-7. doi: 10.1002/chir.530030206. Chirality. 1991. PMID: 1830752

10

Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues.

Shams G, Romstedt KJ, Gerhardt MA, Harrold MW, Miller DD, Feller DR. Shams G, et al. Among authors: miller dd. Eur J Pharmacol. 1990 Aug 2;184(1):21-31. doi: 10.1016/0014-2999(90)90663-q. Eur J Pharmacol. 1990. PMID: 1976530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

841 results

Search Page

Filters